Healthcare

ImmunityBio has initiated a new clinical study, marking a strategic expansion of its development pipeline. The U.S. biotechnology firm announced...

Acadia Pharmaceuticals has encountered a significant obstacle for its European expansion strategy. Market uncertainty followed the announcement of a negative...

Shares of UnitedHealth Group came under significant pressure this week following a regulatory announcement that fell dramatically short of industry...

ImmunityBio has entered February with significant operational momentum, driven by surging revenue, greater clarity from U.S. regulators, and initial international...

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic...

Investor attention is turning to Bio-Rad Laboratories as the company prepares to release its fourth-quarter and full-year 2025 financial results....

Elanco Animal Health is entering the new trading month with significant momentum. A combination of raised price targets from major...

A significant regulatory roadblock has been removed for Intellia Therapeutics. The U.S. Food and Drug Administration (FDA) has lifted the...

A significant regulatory milestone has been achieved by BioNTech in the United States, providing fresh impetus for one of its...

Positive developments in oncology and an analyst upgrade are providing a lift for GE Healthcare Technologies shares as the company...